Lv11
60 积分 2022-05-10 加入
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2小时前
待确认
Successful Osimertinib Rechallenge After Relapse Following Adjuvant Osimertinib: A Case Report
4个月前
已完结
Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer
4个月前
已完结
ALK rearrangement is an independent predictive factor of unexpected nodal metastasis after surgery in early stage, clinical node negative lung adenocarcinoma
5个月前
已完结
Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment
6个月前
已完结
Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group
6个月前
已完结
Lorlatinib: First Global Approval
6个月前
已完结
A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX)
7个月前
已完结
Vorolanib (X-82), an oral anti-VEGFR/PDGFR/CSF1R tyrosine kinase inhibitor, with everolimus in solid tumors: results of a phase I study
7个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
7个月前
已完结
KEYNOTE-522: Phase III study of pembrolizumab (pembro) + chemotherapy (chemo) vs placebo (pbo) + chemo as neoadjuvant treatment, followed by pembro vs pbo as adjuvant treatment for early triple-negative breast cancer (TNBC)
2年前
已采纳
Meta-analysis of genome-wide association studies and functional assays decipher susceptibility genes for gastric cancer in Chinese populations
2年前
已采纳
皖公网安备34019202002308
